Background: Pediatric diffuse intrinsic pontine glioma (DIPG) remains dismal regardless the new therapeutic and technical advances. Objective: To investigate the value of magnetic resonance imaging (MRI) in predicting DIPG prognosis. Patients and methods: Twenty-five DIPG patients with 95 (initial and post radiotherapy) MR examinations were studied. Hydrocephalus was detected in 6 cases (24%), basilar artery encasement in 20 (80%), ill defined border in 16 (64%), perilesional edema in 2 cases (8%) and none showed leptomeningeal spread. Conformal 3-dimensional radiotherapy (39 Gy/13 fractions or 54 Gy/30 fractions) was applied. Results: The median overall survival (MOS) was 9.3 months (95% CI: 7.9-10.8) and the one year overall survival was 18 ± 8.9%. Post radiation MRI performed 3-6 months after treatment showed regression in 8 cases (32%), stationary course in 5 (20%) and progression in 12 cases (48%). The MOS was higher in children whose MRI showed regression (10.0, CI: 6.3-13.7) than those with
radiological progression (8.0, CI: 5.9-10.1 months) or stationary course (7.0, CI: 4.9-9.1). However; these differences did not rank to the level of significance. There was no statistical association of tumor size (p = 0.907), presence of hemorrhage (p = 0.314), or surrounding edema (p = 0.263); entrapment of the basilar artery (p = 0.782); pattern of enhancement (p = 0.851); and hydrocephalus (p = 0.354) with the length of the overall survival. Conclusions: Though MRI is the mainstay for the diagnosis of DIPG, yet its prognostic value is limited. New MR techniques as MR spectroscopy and diffusion tensor imaging should be evaluated as additional tools for prognostic evaluation of DIPG.
Introduction
Diffuse intrinsic pontine glioma remains one of the most challenging solid tumors to be treated in children. The incidence of these tumors is rare, with an estimated 300 children newly diagnosed in the United States each year with a peak incidence between 5 and 9 years (1, 2) . The majority of these tumors arises in the pons and usually present with short duration of signs and symptoms but with significant neurologic impairment. Essentially; brain stem gliomas are divided into two main categories; 20% being low grade, arising in the midbrain, medulla or dorsal pons, often focal and dorsally exophytic, amenable to surgical resection and with a relatively good prognosis. The remaining 80% of the tumors arise and occupy the majority of the pons and are diffuse in nature with a dismal prognosis. This latter group termed DIPG remains one of the most challenging pediatric tumors.
Radiation therapy is the standard treatment, providing transient palliation of the neurological symptoms in 75-85% of patients. Conventional radiotherapy for brain stem glioma has been associated with an overall median survival of 8-11 months. Despite advances in radiation therapy techniques, primary tumor progression remains the major cause of death in patients with DIPG (3, 4) .
The typical MRI findings in DIPG are intrinsic, pontine based infiltrative lesion; hypointense in T1 weighted images (T1WIs) and hyperintense in T2 sequences, with a significant mass effect on the adjacent structures. These findings are diagnostic, making histological confirmation unnecessary (5) .
Although MR images have been shown to be able to demonstrate the response to therapy in DIPG (6, 7) , still there is a debate about the ability of MRI to predict survival in children suffering from these tumors. The aim of this retrospective study is to try to reveal this debate through radiological reviewing of a series of children with DIPG treated at our institute.
Patients and methods
After obtaining the approval of our hospital's institutional review board (IRB), the study was activated. The computerized oncology records of 25 pediatric patients with DIPG treated in our hospital over 4 years period between July, 2007 and June, 2011 have been reviewed. Ninety-five MRI studies of these patients have been reviewed which were performed upon diagnosis, after completion of radiotherapy course and during follow up. These 25 patients were selected from a total of 59 DIPG patients treated during this period. Thirty-four patients were excluded from the study as they never performed a MRI examination after completion of treatment.
For inclusion in this study the lesion has to be pontine in origin which means that the center of the lesion has to be in the pons and involves >50% of its axial area.
MRI studies were performed using Siemens Magnetom Espree 1.5T MRI System with a standard head coil. Prior to contrast injection; axial FLAIR, axial T2 WIs, axial T1 WIs, sagittal T2 WIs and coronal T1 sequences were obtained. After contrast injection (gadopentate dimeglumine 0.2 mmol/kg); axial, sagittal and coronal T1WIs were acquired. Patients below the age of 5 years (7/25 = 28%) were sedated with sevoflurane using MRI compatible anesthesia machine.
The images were reviewed on PACS workstation. The radiologists were blinded to the identity and clinical status of the patients. All measurements were made on the three planes; axial, sagittal and coronal sequences.
Each MRI examination was analyzed for the following: tumor site, size, volume, extension, border (well defined or ill defined), signal intensity, pattern of enhancement; presence of hemorrhage, necrosis, surrounding edema; exophytic growth; entrapment of the basilar artery; leptomeningeal spread and hydrocephalus.
Exophytic growth was defined as extension of the tumor into the adjacent cistern or ventricle. The basilar artery was considered entrapped when more than 180°of its perimeter was encircled by the tumor.
The maximum anteroposterior diameter (d1) of the tumor was measured in axial and sagittal planes; the maximum transverse diameter (d2) was measured in axial and coronal planes while the maximum craniocaudal diameter (d3) was measured in the sagittal and coronal planes. The tumor volume was calculated as d1 · d2 · d3 · 0.54.
If multiple discrete lesions were present, only the largest one was measured while the other smaller lesions were analyzed regarding their signal intensity and pattern of enhancement only.
A progressive course was considered when there was an increase in the volume of the tumor >25% of its original volume while a regressive course was considered when there was a decrease in the volume of the tumor >25% of the original volume. When the change in the tumor volume was <25% either by increase or decrease, this was considered a stationary course.
Newly developed lesions, increased enhancement of the tumor, more involvement of brain stem segments, hydrocephalus and leptomeningeal spread were considered as other features of progression while decreased enhancement of the tumor with increased or newly developed areas of breaking down were considered features of regression.
Each scan was compared to the previous one taking into consideration all the previously mentioned points.
The MR images were evaluated independently by two radiologists (A.M.A and A.R.); disagreement was resolved by joint reevaluation.
The medical charts were reviewed for gender, age, symptoms at diagnosis, lag from appearance of symptoms to diagnosis, clinical examinations on follow up and the length of follow up. The parameters recorded from the clinical evaluation were cranial nerve palsy, paresis, ataxia and level of consciousness. The clinical findings were graded as stable, improved or worsened and were compared to the grading from the nearest MRI scan. New onset of cranial nerve palsy, paresis, ataxia, involvement of additional nerves, or motor impairment of additional limbs and decrease in the level of consciousness were considered clinical worsening. Reversal of this pattern was defined as improvement. The interval between the clinical and the imaging evaluation was recorded.
Statistical analysis
The overall survival rates were calculated using the Kaplan-Meier product-limit method. All possible clinical and radiological parameters that could affect the overall survival were analyzed using the Log Rank test.
Results
The study group consists of 25 patients (95 MRI examinations), 16 boys and 9 girls aged 3-16 years (median 9 years). The patients' characteristics are shown in Table 1 . The patients presented prior to radiotherapy with at least two of the following symptoms; cranial nerve palsy (88%), ataxia (48%) or long tract deficits (64%). All patients had a duration of these symptoms of 3 months or less with a median of one month.
All patients received radiation therapy as a primary treatment. Eleven of the 25 patients received the prescribed dose of 3900 cGy in 13 fractions of 300 cGY and 14 patients received the prescribed dose of 5400 cGy in 30 fractions of 180 cGy. The clinical target volume (CTV) included the tumor as defined by the MR T2WIs with a margin of 1.5 cm. These margins were adjusted for bony structures and tentorium. Another margin of 0.5 cm is added to create the planning target volume (PTV) to compensate for systematic and random errors according to the department policy. No neoadjuvant, con-comitant or adjuvant systemic treatments were given apart from steroids.
The imaging findings at the initial diagnosis are summarized in Table 2 . Eighteen cases were located in the pons, one case in the pons and left cerebellum, three cases in the pons and medulla, two cases in the pons and midbrain and one case in the pons, medulla and left cerebellar hemisphere.
All cases have diffuse lesions and six of them had exophytic component in addition.
Upon presentation; 23 cases (92%) showed T2 and FLAIR WIs high signal intensity while two cases (8%) were isointense to the surrounding brain stem parenchyma. On T1WIs; fifteen cases (60%) were hypointense; four cases (16%) were isointense to the brain stem parenchyma and six cases contained hemorrhagic elements seen as high signal intensity. After contrast injection, eleven cases (44%) did not show enhancement while fourteen (56%) cases show different patterns of enhancement.
Hydrocephalus was present in six cases (24%); basilar artery encasement was seen in twenty cases (80%), nine cases had well defined tumor border (36%) while sixteen cases had ill defined borders (64%), necrosis was seen in eight cases (32%) and two cases (8%) showed peritumoral edema.
None of the patients showed any leptomeningeal spread at the time of diagnosis but two cases developed leptomeningeal spread as a sign of progression.
On follow up, comparison of MRI 3-6 months post radiotherapy to the initial one showed radiologically progressive course of the disease in twelve cases. This progression presented by different radiological patterns is shown in Table 3 .
Radiological regression of the disease was seen in eight cases and presented in Table 4 .
The condition was radiologically stationary in five cases. On follow up, progression of the disease was clinically evident in 15 cases but only 9 of them were confirmed radiologically. The disease was stable clinically and radiologically in 4 cases, stable clinically but showed regression in MRI in another 3, while clinically stable in 1 patient but showed progression in MRI. The disease was improved clinically in 2 cases but showed progression by MRI (Table 5) . Figs. 1 and 2 show the dissociation between the radiological features of the tumor post radiation and the clinical condition of the patient.
The median overall survival (MOS) for the 25 children was 9.3 months (95% CI: 7.9-10.8) and the one year overall survival rate was 18 ± 8.9% (Fig. 3) .
There was no statistical association of tumor size (p = 0.907), presence of hemorrhage (p = 0.314), or surrounding edema (p = 0.263); entrapment of the basilar artery (p = 0.782); pattern of enhancement (p = 0.851); and hydrocephalus (p = 0.354) with the length of the overall survival.
MRI-regression children had MOS of 10.0 months (CI: 6.3-13.7) that was higher than those showing MRI progression (8.0, CI: 5.9-10.1 months) or stationary condition (7.0, CI: 4.9-9.1). However; these differences did not rank to the level of significance (p = 0.096) ( Fig. 4 ).
Discussion
Diffuse intrinsic pontine gliomas typically involve more than one half of the affected brain stem segment. However; they may infiltrate brain stem segments cranial or caudal to the origin (8) . Diffuse gliomas comprise around 90% of brain stem tumors in children with peak incidence between 5 and 10 years (9) .
The classic clinical triad at presentation consists of ataxia, long tract signs and cranial nerve deficits. Cranial nerves VI and VII are typically involved as these tumors are mainly located in the pons (10) .
In the present study, patients presented with at least two of these symptoms; cranial nerve palsy (88%), ataxia (48%) or long tract deficits (64%). All patients had a duration of these symptoms of a median of one month.
In the last 20 years, pediatric neuro-oncology has benefited from a number of advances. New neuroradiological tools have become available, such as MR spectroscopy, MR diffusion, MR diffusion tensor and PET, with their specific diagnostic potential. Radiotherapeutic techniques have improved as well, enabling the doses delivered to the tumor to be increased without further harming the healthy brain. In the majority of cases, the diagnosis of DIPG and the treatment decision are based solely on MR imaging without biopsy, because of fear of associated complications. However, data from previous MR studies revealed that diffuse pontine tumors have worse prognosis than dorsally exophytic, focal and midbrain centered tumors (3) .
Studies correlating the clinical presentation and the tumor characteristics with outcome are scarce. The identification of imaging signs that could help clinicians predict response to therapy and length of survival would be highly contributory to the management of these patients (11) .
Our study analyzed a pure population of DIPG, with the lesion centered in the pons and involves more than 50% of the axial area. From this group we were unable to find any predictive prognostic factor that correlated with the survival. Tumor size, presence of hemorrhage, surrounding edema; entrapment of the basilar artery; pattern of enhancement and hydrocephalus did not predict the subsequent course of the disease. This finding is contradictory to what has been achieved by Fisher et al., as their studies included exophytic, focal and midbrain centered tumors. Furthermore, their studies suggested that duration of symptoms, gadolinium enhancement and basilar artery encasement all had prognostic significance. These clinical and MRI variables differentiate DIPG from other less aggressive brain stem gliomas.
However, our findings were nearly comparable to Kornreich et al. (7) , as they did not find any association between the imaging findings at diagnosis and the length of survival. The single prognostic sign in their study was the presence of hydrocephalus at diagnosis, which was associated with a shorter progression-free survival (P = 0.02), probably due to rapid tumor growth (15) .
The median overall survival for our patients was 9.3 months which is nearly comparable with other reports with a median overall survival ranges from 8 to 11 months (16) (17) (18) . Two studies (19-20) had longer median overall survival than our study of 15 months and 16 months respectively; they did not provide information on clinicoradiological eligibility and included some patients with duration of symptoms of up to 12 months. Furthermore, only 50% (8/16) of Wakabayashi et al. (20) were diagnosed as DIPG; the remaining 50% were pure focal or exophytic brainstem gliomas. Local relapse has been extensively documented in many series as the primary mode of failure in DIPG (21) (22) (23) , that is why we did not undergo in our study routine neuraxis imaging after initial therapy and spinal imaging were reserved for symptomatic patients. However; study done by Sethi et al. (24) recommended that all DIPG patients undergo spine and brain MRI scans at the time of initial presentation and at regular intervals during follow up as high incidence of leptomeningeal disease was observed at diagnosis and recurrence. In their study, patients with leptomeningeal involvement had shorter overall survival compared to patients with localized disease. Some form of CNS prophylaxis should be considered in future clinical trials (24) .
In a study done by Ibrahim et al. (25) , diffusion tensor imaging provided information which further defined precise relations between the sub cortical white matter structures and the brain tumors which potentially has a role in tumor characterization and preoperative planning (25) . 
Conclusion
Magnetic Resonance Imaging is still the mainstay for the diagnosis and follow up of diffuse intrinsic pontine glioma. However, the prognostic value of this imaging modality is limited. New magnetic resonance techniques such as MR spectroscopy and diffusion tensor imaging should be evaluated as additional tools for the management of these tumors.
